Akebia Therapeutics
AKBA
#7041
Rank
HK$3.09 B
Marketcap
HK$14.17
Share price
1.68%
Change (1 day)
83.56%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -HK$5.02

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$4.98. In 2022 the company made an earnings per share (EPS) of -HK$3.97 an increase over its 2021 EPS that were of -HK$13.23.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$5.0226.47%
2022-HK$3.97-70%
2021-HK$13.23-38.63%
2020-HK$21.5617.37%
2019-HK$18.372.79%
2018-HK$17.8731.2%
2017-HK$13.62-51.39%
2016-HK$28.0257.89%
2015-HK$17.75-94.83%
2014-HK$343.34589.75%
2013-HK$49.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$110.14-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.11-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$109.64-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$12.69 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA